---
title: Frontage Laboratories vs Syngene International
slug_a: frontagelab
slug_b: syngeneintl
site: cro
review_signal_gate: closed
canonical_path: /compare/frontagelab/syngeneintl
generated_by: BioBM Editorial AI
---

# Frontage Laboratories vs Syngene International

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Frontage Laboratories (frontagelab) is listed for cro. Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.

Services: 37. Modalities: 5. Indications: 1. Locations: 2. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (37).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Syngene International (syngeneintl) is listed for both. Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

Services: 100. Modalities: 10. Indications: 14. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (100).

Review summary: Review summary withheld until site-level review gate opens.